Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas

Human Pathology

Volumn 27, Issue 12, 1996, Pages 1355-1360

  Gilcrease, Michael Z ^a,b   Truong, Luan ^a   Brown, Richard W ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

CD44; cell adhesion molecule; immunohistochemistry; invasive; metastatic; renal cell carcinoma; VLA integrin

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; VERY LATE ACTIVATION ANTIGEN;

ARTICLE; CANCER GRADING; CANCER INVASION; CELL ADHESION; CELL CONTACT; CELL INTERACTION; DNA DETERMINATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; NEPHRECTOMY; PLOIDY; PREOPERATIVE EVALUATION; T LYMPHOCYTE; TUMOR VOLUME;

EID: 0029826638     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90350-0     Document Type: Article

References (42)

1. Albeda SM: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68:4-17, 1993
2. Hogg N, Landis RC: Adhesion molecules in cell interactions. Curr Opin Immunol 5:383-390, 1993
3. Ruoslahti E: Control of cell motility and tumor invasion by extracellular matrix interactions. Br J Cancer 66:239-242, 1992
4. Chamas R, Brentani R: Integrins and metastases: An overview. Tumor Biol 12:309-320, 1991
5. Ruoslahti E, Giancotti FG: Integrins and tumor cell dissemination. Cancer Cells 1:119-126, 1989
6. Hemler ME, Elices MJ, Chan BMC, et al: Multiple ligand binding functions for VLA-2 and VLA-3 in the integrin family. Cell Differ Dev 32:229-238, 1990
7. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu Rev Immunol 8:365-400, 1990
8. Aruffo A, Stamenkovic E, Melnick M, et al: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990
9. Gallatin WM, Rosenman SJ, Ganji A, et al: Structure-function relationships of the CD44 class of glycoproteins. Cell Mol Mech Inf 2:131-150, 1991
10. Culty M, Miyake K, Kincade PW, et al: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoprotcins. J Cell Biol 111:2765-2774, 1990
11. Gunthert U, Hormann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991
12. Stamenkovic I, Aruffo A, Amiot M, et al: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348, 1991
13. Arch R, Wirth K, Hofmann M, et al: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (Washington) 257:682-685, 1992
14. Liotta L: Tumor invasion and metastases: Role of the extra-cellular matrix. Cancer Res 46:1-7, 1986
15. Lauri D, Martin-Padura I, Biondelli T, et al: Role of beta-1 integrins in tumor cell adhesion to cultured human endothelial cells. Lab Invest 65:525-531, 1991
16. Conforti G, Dominguez-Jimenez C, Zanetti A, et al: Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 80:437-446, 1992
17. Kawaguchi S, Kikuchi K, Ishii S, et al: VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Jpn J Cancer Res 83:1304-1316, 1992
18. Holland JM: Cancer of the kidney: Natural history and staging. Cancer 32:1030-1042, 1973
19. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663, 1982
20. Medeiros LJ, Gelb AB, Weiss LM: Renal cell carcinoma: Prognostic significance of morphologic parameters in 121 cases. Cancer 61:1639-1651, 1988
21. Ekfors TO, LipastiJ, Nurmi MJ, et al: Flow cytometric analysis of the DNA profile of renal cell carcinoma. Pathol Res Pract 182:58-62, 1987
22. Korhonen M, Laitinen L, Ylanne J, et al: Integrin distributions in renal cell carcinomas of various grades of malignancy. Am J Pathol 141:1161-1171, 1992
23. Terpe HJ, Tajrobehkar K, Gunthert U, et al: Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas: An immunohistochemical study. Virchows Arch [A] Pathol Anat 422:219-224, 1993
24. Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327, 1983
25. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC method and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
26. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663, 1982
27. Kajiji S, Tamura RN, Quaranta V: A novel integrin (alpha-E/beta-4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J 8:673-680, 1989
28. Korhonen M, Laitinen L, Ylanne J, et al: Integrins in developing, normal and malignant human kidney. Kidney Int 41:641-644, 1992
29. Goligorsky MS, Lieberthal W, Racusen L, et al: Integrin receptors in renal tubular epithelium: New insights into pathophysiology of acute renal failure. Am J Physiol 264:F1-F8, 1993
30. Miettinen M, Castello R, Wayner E, et al: Distribution of VLA integrins in solid tumors: Emergence of tumor-type related expression patterns in carcinomas and sarcomas. Am J Pathol 142:1009-1018, 1993
31. Damjanovich L, Albeda SM, Mette SA, et al: The distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol 6:197-206, 1992
32. Pignatelli M, Cardillo MR, Hanby A, et al: Integrins and their accessory adhesion molecules in mammary carcinomas: Loss of polarization in poorly differentiated tumors. HUM PATHOL 23:1159-1166, 1992
33. Koukoulis GK, Virtanen I, Korhonen M, et al: Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 139:787-799, 1991
34. Stallmach A, Lampe BV, Mathes H, et al: Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumor transformation. Gut 33:342-346, 1992
35. Weinel RJ, Rosendahl A, Neumann K, et al: Expression and function of VLA alpha-2, alpha-3, alpha-5, and alpha-6 integrin receptors in pancreatic carcinoma. Int J Cancer 52:827-833, 1992
36. Volpes R, van den Oord JJ, Desmet VJ: Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 142:1483-1492, 1993
37. Peltonen J, Larjava H, Jaakkola S, et al: Localization of integrin receptors for fibronectin, collagen, and laminin in human skin: Variable expression in basal and squamous cell carcinomas. J Clin Invest 84:1916-1923, 1989
38. Carey TE, Nair TS, Chern C, et al: Blood group antigens and integrins as biomarkers in head and neck cancer: Is aberrant tyrosine phosphorylation the cause of altered alpha-6-beta-4 integrin expression? J Cell Biochem 17F:223-232, 1993 (suppl)
39. Carico E, French D, Bucci B, et al: Integrin beta-4 expression in the neoplastic progression of cervical epithelium. Gynecol Oncol 49:61-66, 1993
40. Grone HJ, Weber K, Helmchen U, et al: A marker of brush border differentiation and cellular origin in human renal cell carcinoma. Am J Pathol 124:294-302, 1986
41. Hemler ME, Kassner PD, Chan BMC: Functional roles for integrin alpha subunit cytoplasmic domains. Cold Springs Harb Symp Quant Biol 8:213-220, 1992
42. Koopman G, van Kooyk Y, deGraaff M, et al: Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Biol Chem 145:3589-3593, 1992